Recently, significant developments have been made in understanding the mechanisms involved in initial host recognition to viral infections, and how this viral recognition leads to the immune response. The viral recognition is mediated by pattern recognition receptors (PRR), which are a primeval part of the immune system. PRR is the protein expressed by cells of the innate immune system to identify highly conserved structural motifs known as pathogen-associated molecular patterns (PAMP). PAMP are exclusively expressed by microorganisms which include viral double-stranded RNA and various bacterial cell wall components such as lipopolysaccharide, and bacterial DNA.
Toll like receptors (TLR) are the most eminent members of the PRR. TLR owe their names to a famous Drosophila gene, Toll (in German Toll, means super or fantastic).  Ten human toll like receptors (TLR1 to TLR10) have been characterized so far. TLR is a type I transmembrane protein characterized by an extracellular domain containing leucine-rich repeats and a cytoplasmic extension that contains a conserved region called the Toll/IL-1 receptor domain. TLR is located on the plasma membrane with the exception of TLR3, TLR7, and TLR9 which are localized in the endosomal compartment. TLR are mainly expressed in tissues involved in immune function, such as spleen and peripheral blood leukocytes. Their expression profiles vary between tissues and cell types.
TLR recognition with their corresponding PAMP triggers two distinct pathways: a MyD88-dependent pathway that leads to the production of inflammatory cytokines, and MyD88-independent pathway associated with the stimulation of interferons-?? (IFN).
Herpes simplex viral (HSV) double stranded RNA is recognized by the endosomal TLR. After binding to its cognate, TLR activates the adapter protein, TRIF, in a MyD88-independent pathway. TRIF (Toll / Interlukin-1 receptor domain containing adapter protein) combines with a protein kinase TBK1 (TANK binding kinase 1) to produce interferon regulatory factors (IRF 3 and IRF 7) which subsequently produces IFN-??, resulting in antiviral activity [Figure.1].  There are yet other receptors in the cytoplasm called RLR (retinoic acid inducible gene, RIG like receptors) which also recognize the viral RNA and work together with TLR in the production of IFN-??.
But, HSV has a unique way to evade this anti-viral IFN- ?? response by producing serine protease NS3/4A (degrades the cellular adapter protein TRIF) and immediate early protein ICP0 (prevents the aggregation of activated IRF-3). 
Clinical and virological manifestations of genital HSV-2 infections vary widely due to the single-nucleotide polymorphisms in TLR. Studies proved that polymorphisms in TLR 2 had resulted in increased HSV-2 genital shedding. Alexandra Svensson et al in their study suggested that the absence of TLR3 functional activity predisposes children to HSV-1 encephalitis.  Apart from genetic variations in TLR which modify the course of HSV illness, Resiquimod, a TLR 7 and TLR 8 agonist also decreases HSV-2 genital shedding. 
Thus the critical role played by TLR in innate immunity has been a tremendous advancement in the pathogenesis of HSV infection and more treatment options could be tried in this line.
...(download the rest of the essay above)